Description

An Innovative Dual GIP and GLP-1 Agonist

GLP2T is a cutting-edge compound designed as a dual receptor agonist for GIP (Glucose-dependent insulinotropic polypeptide) and GLP-1 (Glucagon-like peptide-1). Engineered for advanced research applications, GLP2T empowers researchers to delve deeper into glucose metabolism and related studies.

Important Disclaimer

This compound has not been evaluated by the FDA and is not intended for diagnosing, treating, curing, or preventing any disease. It is strictly intended for laboratory use and must be utilized by qualified researchers or institutions in compliance with institutional and regulatory guidelines.

Terms of Sale and Buyer Responsibility

By purchasing GLP2T, the buyer agrees to assume full responsibility for its handling, usage, and adherence to relevant regulations. Please note that all sales are final, and this compound is intended exclusively for research purposes, not for medical or therapeutic use.